Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Neuroendocrine dysfunction in polycystic ovary syndrome.

Burt Solorzano CM, Beller JP, Abshire MY, Collins JS, McCartney CR, Marshall JC.

Steroids. 2012 Mar 10;77(4):332-7. doi: 10.1016/j.steroids.2011.12.007. Epub 2011 Dec 8. Review.

2.

The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.

Blank SK, McCartney CR, Marshall JC.

Hum Reprod Update. 2006 Jul-Aug;12(4):351-61. Epub 2006 May 2. Review.

PMID:
16670102
3.

Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.

Blank SK, McCartney CR, Helm KD, Marshall JC.

Semin Reprod Med. 2007 Sep;25(5):352-9. Review.

PMID:
17710731
4.

Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.

McCartney CR, Eagleson CA, Marshall JC.

Semin Reprod Med. 2002 Nov;20(4):317-26. Review.

PMID:
12536355
6.

Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.

Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC.

J Clin Endocrinol Metab. 2000 Nov;85(11):4047-52.

PMID:
11095431
7.

Neuroendocrine aspects of polycystic ovary syndrome.

Marshall JC, Eagleson CA.

Endocrinol Metab Clin North Am. 1999 Jun;28(2):295-324. Review.

PMID:
10352920
8.

Neuroendocrine control in polycystic ovary-like syndrome.

Schoemaker J.

Gynecol Endocrinol. 1991 Dec;5(4):277-88. Review.

PMID:
1796749
9.
10.

Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome.

McGee WK, Bishop CV, Bahar A, Pohl CR, Chang RJ, Marshall JC, Pau FK, Stouffer RL, Cameron JL.

Hum Reprod. 2012 Feb;27(2):531-40. doi: 10.1093/humrep/der393. Epub 2011 Nov 23.

11.

The gonadotropic axis in hyperandrogenic adolescents.

Taylor AE.

J Pediatr Endocrinol Metab. 2000;13 Suppl 5:1281-4.

PMID:
11117670
12.

Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.

Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.

J Clin Endocrinol Metab. 1996 Aug;81(8):2854-64.

PMID:
8768842
13.

Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.

Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC.

J Clin Endocrinol Metab. 1998 Feb;83(2):582-90.

PMID:
9467578
14.
15.

Prenatal androgen excess enhances stimulation of the GNRH pulse in pubertal female rats.

Yan X, Yuan C, Zhao N, Cui Y, Liu J.

J Endocrinol. 2014 Jul;222(1):73-85. doi: 10.1530/JOE-14-0021. Epub 2014 May 14.

16.

Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity.

Rosenfield RL, Bordini B.

Brain Res. 2010 Dec 10;1364:186-97. doi: 10.1016/j.brainres.2010.08.088. Epub 2010 Sep 25. Review.

17.

Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls.

Chhabra S, McCartney CR, Yoo RY, Eagleson CA, Chang RJ, Marshall JC.

J Clin Endocrinol Metab. 2005 May;90(5):2810-5. Epub 2005 Feb 22.

PMID:
15728200
18.

Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.

Arroyo A, Laughlin GA, Morales AJ, Yen SS.

J Clin Endocrinol Metab. 1997 Nov;82(11):3728-33.

PMID:
9360532
19.

Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models.

Roland AV, Moenter SM.

Front Neuroendocrinol. 2014 Oct;35(4):494-511. doi: 10.1016/j.yfrne.2014.04.002. Epub 2014 Apr 18. Review.

20.

Supplemental Content

Support Center